VASCULAR PHARMACOLOGY

Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.

The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease

Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects.

Long non-coding RNAs in vascular biology and disease.

Non-coding RNAs in vascular remodeling and restenosis.

The function of long non-coding RNAs in vascular biology and disease.

Linking diabetic vascular complications with LncRNAs.

Non-coding RNAs in lipid metabolism.

Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis.

Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y12 antagonists.

Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta.

Amorphous nano-selenium quantum dots improve endothelial dysfunction in rats and prevent atherosclerosis in mice through Na+/H+ exchanger 1 inhibition.

Oxidative stress and vascular stiffness in hypertension: A renewed interest for antioxidant therapies?

Asiatic acid stabilizes cytoskeletal proteins and prevents TNF-α-induced disorganization of cell-cell junctions in human aortic endothelial cells.

Vascular angiotensin AT1 receptor neuromodulation in fetal programming of hypertension.

Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.

Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohort.

Alogliptin improves endothelial function by promoting autophagy in perivascular adipose tissue of obese mice through a GLP-1-dependent mechanism.

Non-coding RNAs in aneurysmal aortopathy.

Switching between P2Y12 antagonists - From bench to bedside.

Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1.

Inflammation and myointimal hyperplasia. Correlation with hemodynamic forces.

CRISPR links to long noncoding RNA function in mice: A practical approach.

Treatment of cyclosporine induced hypertension: Results from a long-term observational study using different antihypertensive medications.

Long non-coding RNA-SRA promotes neointimal hyperplasia and vascular smooth muscle cells proliferation via MEK-ERK-CREB pathway.

Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy.

The endothelial status reflected by circulating endothelial cells, circulating endothelial progenitor cells and soluble thrombomodulin in patients with mild and resistant hypertension.

Ex vivo microangioCT: Advances in microvascular imaging.

HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression.

Drug-induced hypertension: Know the problem to know how to deal with it.

Role of amino acid metabolism in angiogenesis.

Variety matters: Diverse functions of monocyte subtypes in vascular inflammation and atherogenesis.

Microbiota are critical for vascular physiology: Germ-free status weakens contractility and induces sex-specific vascular remodeling in mice.

SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification.

Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.

Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL study.

Long non-coding RNAs: A crucial part of the vasculature puzzle.

Everolimus depletes plaque macrophages, abolishes intraplaque neovascularization and improves survival in mice with advanced atherosclerosis.

Rapid effects of aldosterone on platelets, coagulation, and fibrinolysis lead to experimental thrombosis augmentation.

Elevated luteinizing hormone contributes to atherosclerosis formation by inhibiting nitric oxide synthesis via PI3K/Akt pathway.

Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model.

LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway.

GLP-1-based therapies to boost autophagy in cardiometabolic patients: From experimental evidence to clinical trials.

Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation.

Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity.

Lessons learned from a lncRNA odyssey for two genes with vascular functions, DLL4 and TIE1.